Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature

Journal of Endocrinological Investigation

Volumn 19, Issue 6, 1996, Pages 348-352

  Davila N ^a,c   Moreira Andres M ^b   Alcaniz J ^a   Barcelo B ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

GHBP receptor; ISS

Indexed keywords

CARRIER PROTEIN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; SOMATOMEDIN C; SOMATOTROPIN BINDING PROTEIN; SOMATOTROPIN-BINDING PROTEIN;

ARTICLE; BLOOD; BODY HEIGHT; CHILD; FEMALE; GROWTH DISORDER; HUMAN; MALE; METABOLISM; PRESCHOOL CHILD; REFERENCE VALUE;

BODY HEIGHT; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; RECEPTORS, SOMATOTROPIN; REFERENCE VALUES;

EID: 0030157934     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344968     Document Type: Article

References (31)

1. Zadik Z., Chalew S., Baiti S., Kowarski A. Do short children secrete insufficient growth hormone? Pediatrics 176: 355, 1985.
2. Albertsson-Wikland K., Rosberg S. Analysis of 24-hour growth hormone profiles in children: relation to growth. J. Clin. Endocrinol. Metab. 67: 493, 1988.
3. Kerrigan J.R., Martha P.M., Blizzard R.M., Christie C.M., Rogol A.D. Variations of pulsatile growth hormone release in healthy short prepubertal boys. Pediatr. Res. 28: 11, 1990.
4. Veldhuis D.J., Blizzard R.M., Rogol A.D., Martha P.M., Kirkland Jr. J.R., Sherman B.M. Genentech Collaborative Study Group. J. Clin. Endocrinol. Metab. 74: 766, 1992.
5. Fontoura M., Mugnier E., Bruner R., Rappaport R., Postel-Vinay M.C. Effect of growth hormone on the low level of growth hormone binding protein in idiopathic short stature. Clin. Endocrinol. (Oxf.) 37: 249, 1992.
6. Carlsson L.M.S., Attie K., Compton P.G., Vitangcol R.V., Merimee T.J., and The National Cooperative Growth Study. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. J. Clin. Endocrinol. Metab. 78: 1325, 1994.
7. Goddard A.D., Covello R., Louh S.M., Clackson T., Attie K.M., Gesundheit N., Rundle A.C., Wells J.A., Carlsson L.M.S. Mutations of the growth hormone receptor in children with idiopathic short stature. N. Engl. J. Med. 333: 1093, 1995.
8. Baumann G., Stolar M.W., Amburn K., Barsano C.P., Devries B.C. A specific growth-hormone binding protein in human plasma: initial characterization. J. Clin. Endocrinol. Metab. 62: 134, 1986.
9. Herington A.C., Ymer S., Stevenson J. Identification and characterization of specific binding proteins for growth hormone in normal human sera. J. Clin. Invest. 77: 1817, 1986.
10. Silbergeld A., Lazar L., Erster B., Tepper R., Laron Z. Serum growth hormone-binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clin. Endocrinol. (Oxf.) 31: 295, 1989.
11. Baumann G., Shaw M.A., Amburn K. Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism 38: 683, 1989.
12. Baumann G., Shaw M., Winter R.J. Absence of serum growth hormone binding protein in Laron type dwarfism. J. Clin. Endocrinol. Metab. 65: 814, 1987.
13. Daughaday W.H., Trivedi B. Absence of serum growth hormone receptor deficiency (Laron dwarfism). Proc. Natl. Acad. Sci. USA 88: 4636, 1987.
14. Dávila N., Alcañiz J., Salto L., Estrada J., Barceló B., Baumann G. Serum Growth hormone-binding protein is unchanged in adult panhypopituitarism. J. Clin. Endocrinol. Metab. 79: 1347, 1994.
15. Daughaday W.H., Trivedi B., Andrews B. The ontogeny of serum growth hormone (GH)-binding protein in man: a possible indicator of hepatic GH receptor development. J. Clin. Endocrinol. Metabab. 65: 1072, 1987.
16. Tar A., Hocquette F., Souberbielle J., Clot J.P., Brauner R., Postel Vinay M.C. Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration. J. Clin. Endocrinol. Metab. 71: 1202, 1990.
17. Massa G., Bouillon R., Vanderschuren-Lodeweyck M. Serum levels of growth hormone-binding protein and insulin-like growth factor-1 during puberty. Clin Endocrinol. (Oxf.) 37: 175, 1992.
18. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. I. Serum Growth hormone-binding protein. J. Clin. Endocrinol. Metab. 77: 452, 1993.
19. Leung D.W., Spencer S.A., Cachianes G., Hammonds R.G., Collins C., Henzel W., Barnard R., Waters M.J., Wood W.I. Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 330: 537, 1987.
20. Baumann G. Minireview: Growth hormone-binding proteins. Proc. Soc. Exp Biol. Med 202: 392, 1993.
21. Rosenbloom A.L., Guevara Aguirre J., Rosenfeld R.G., Fielder P.J. The little women of Loja-growth hormone receptor deficiency in an inbred population of southern Ecuador. N. Engl. J. Med. 323: 1367, 1990.
22. Godowski P.J., Leung D., Meacham L.R., Galgani J.P., Hellmiss R., Keret R., Rotwein P.S., Parks J.S., Laron Z., Wood W.I. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc. Natl. Acad. Sci USA 86: 8083, 1989.
23. Berg M., Argente J., Chernausek S., Gracia R., Guevara Aguirre J., Hopp M.I., Perez-Jurado L., Rosenbloom A., Toledo S.P.A., Francke U. Diverse growth hormone receptor gene mutations in Laron syndrome. Am. J. Human. Genetics 52: 998, 1993.
24. Amselem S.O., Duquesnoy P., Duriez B., Dastot F., Sobrier M.L., Valleix S., Goossens M. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Human Mol. Genetics 2: 355, 1993.
25. Merimee T.J., Baumann G., Daughaday W. Growth hormone binding protein, II studies in pygmies and normal statured subjects. J. Clin. Endocrinol. Metab. 71: 1183, 1990.
26. Baumann G., Shaw M.A., Brumbaugh R.C., Schwartz J. Short stature and decreased serum growth hormone-binding protein in mountain OK people of Papua New Guinea. J. Clin. Endocrinol. Metab. 72: 1346, 1991.
27. Martha Jr. P.M., Rogol A.D., Blizzard R.M., Shaw M.A., Baumann G. Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. J. Clin. Endocrinol. Metab. 73: 157, 1991.
28. Martha Jr. P.M., Reiter E.O., Dávila N., Shaw M.A., Holcombe J.H., Baumann G. Serum growth hormone-binding protein/receptor: an important determinant of growth hormone responsiveness. J. Clin. Endocrinol. Metab. 75: 1464, 1992.
29. Martha Jr. P.M., Reiter E.O., Holcombe J., Shaw M.A., Baumann G. Serum growth hormone-binding protein (GHBP) activity influences the response to GH replacement therapy in GH deficient children. Pediatr. Res. 29: 81A, 1991.
30. Martha Jr. P.M., Rogol A.D., Blizzard R.M., Holcombe J., Reiter O.E. The relationship of body mass to growth hormone (GH) production and response to therapy: implications for GH replacement dosages. Pediatr Res. 29: 81A (abstract), 1991.
31. Martha Jr. P.M., Reiter E.O., Dávila N., Shaw M.A., Holcombe H., Baumann G. The role of Body Mass in response to Growth Hormone Therapy. J. Clin. Endocrinol. Metab. 75: 1470, 1992.